Winan van Houdt/LinkedIn
May 5, 2025, 15:06
Winan van Houdt: Examining Marc Moncrieff’s PhD on SLNB in Melanoma
Winan van Houdt, Surgical Oncologist at Antoni van Leeuwenhoek and Program Coordinator for Rare Cancers at the Netherlands Cancer Institute, shared a post on LinkedIn:
“Throwback to PhD Viva April 11 – examining Prof Marc Moncrieff together with Thomas Carter at the University of East Anglia. We had no choice but to let him pass without corrections since he is one of the worlds experts of sentinel lymph node biopsy in melanoma and also PI of the Melmart trial. Congrats Marc!”
More posts featuring Winan van Houdt.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 24, 2025, 01:32
Aug 23, 2025, 22:57
Aug 23, 2025, 22:35
Aug 23, 2025, 22:10
Aug 23, 2025, 21:42
Aug 23, 2025, 21:31
Aug 23, 2025, 20:55
Aug 23, 2025, 20:22